- Home
- PRE
PRE
Prenetics Global Limited
as 04-23-2025 4:00pm EST
| Founded: | 2014 | Country: | Hong Kong |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $9.00 | AVG Volume (30 days): | 10.2K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.95 - $7.84 | Next Earning Date: | 06-17-2025 |
| Revenue: | $25,561,362 | Revenue Growth: | -90.86% |
| Revenue Growth (this year): | 51.43% | Revenue Growth (next year): | 131.29% |
Latest Prenetics Global Limited News
PRE Breaking Stock News: Dive into PRE Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 days ago
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
GlobeNewswire
a month ago
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
GlobeNewswire
a month ago
Prenetics to Participate in the 37th Annual ROTH Conference
GlobeNewswire
2 months ago
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
PR Newswire
2 months ago
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
GlobeNewswire
3 months ago
Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham
GlobeNewswire
3 months ago
Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials
GlobeNewswire
4 months ago
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
Compare PRE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRE Prenetics Global Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.